Stock 000623 JILIN AODONG PHARMACEUTICAL GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Jilin Aodong Pharmaceutical Group Co., Ltd.

Equities

000623

CNE000000719

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 20/05/2024 BST 		5-day change 1st Jan Change
14.92 CNY -0.73% Intraday chart for Jilin Aodong Pharmaceutical Group Co., Ltd. -0.93% -1.45%
04-29 Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-17 Aodong Medicine's 2023 Profit Declines 18%; Revenue Up 20% MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Aodong Medicine's 2023 Profit Declines 18%; Revenue Up 20%
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Chinese listed firms used endangered animal parts as ingredients -report
Three listed Chinese firms used endangered animal parts as ingredients- report
Jilin Aodong Pharmaceutical Group Co., Ltd. announces an Equity Buyback for CNY 150 million worth of its shares.
Jilin Aodong Pharmaceutical Group Co., Ltd. authorizes a Buyback Plan.
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. cancelled the acquisition of Beijing Langyan Life Technology Holdings Co., Ltd. from a group of shareholders.
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Jilin Aodong Pharmaceutical Group Co., Ltd. Elects Liang Biming as Independent Director
Aodong Medicine's Unit Gets Registration Certificate for 16 Formula Tablets
Jilin Aodong Pharmaceutical Group Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on July 7, 2023
Jilin Aodong Pharmaceutical Group Co., Ltd Approves the Profit Distribution Proposal for 2022
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Jilin Aodong Pharmaceutical Group Co., Ltd. Announces the Profit Distribution Proposal for 2022
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Jilin Aodong Pharmaceutical Group Co., Ltd. acquired a.25% stake in GF Securities Co., Ltd. for HKD 44.8 million.
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 000623 Stock
  4. News Jilin Aodong Pharmaceutical Group Co., Ltd.
  5. Other languages